aid
acquir
immun
defici
syndrom
remain
great
unconqu
threat
global
public
health
effect
hiv
vaccin
urgent
need
nineti
percent
aid
case
transmit
mucos
rout
sexual
contact
target
immun
respons
site
viral
entri
protect
bodi
help
clear
viral
reservoir
hiv
dissemin
evid
hivspecif
siga
could
neutral
hiv
cervicovagin
lavag
fluid
uninfect
partner
highli
expos
person
sivspecif
ctl
induc
immun
attenu
shiv
found
associ
protect
vagin
challeng
rhesu
macaqu
research
believ
vaccin
would
need
induc
neutral
antibodi
th
compet
ctl
respons
initi
site
viral
entri
system
vaccin
suffici
gener
effect
compartment
mucos
immun
howev
induc
robust
mucos
immun
respons
difficult
sever
factor
contribut
success
mucos
immun
key
factor
follow
effect
deliveri
antigen
mucos
immun
induct
site
ii
enhanc
mucos
immun
respons
via
safe
mucos
adjuv
iii
regimen
rout
immun
induc
protect
respons
desir
mucos
site
prefer
system
iv
adequ
vaccin
formul
vaccinia
viru
vv
use
smallpox
vaccin
help
erad
smallpox
worldwid
live
vaccin
vector
use
prevent
erad
mani
infecti
diseas
due
broad
host
rang
larg
foreign
dna
capac
lack
carcinogen
abil
induc
express
foreign
antigen
eukaryot
cell
recombin
wild
vaccinia
viru
gener
avoid
safeti
reason
particularli
regard
young
children
immunecompromis
individu
result
china
chen
colleg
develop
seri
highli
attenu
vaccinia
viru
tiantan
strain
decreas
neurotox
viru
preliminari
experi
demonstr
highli
attenu
vaccinia
viru
could
induc
humor
cellmedi
immun
respons
one
intranas
immun
viru
protect
anim
challeng
pathogen
vaccinia
wr
strain
nation
center
aidsstd
control
prevent
china
develop
aid
vaccin
candid
use
dna
prime
rvv
tiantan
boost
env
gagpol
insert
approv
sfda
phase
trial
volunt
recruit
start
beij
novemb
unfortun
highli
attenu
recombin
vaccinia
virus
induc
limit
mucos
immun
respons
specif
foreign
antigen
even
high
dose
enhanc
immun
respons
reduc
necessari
dose
would
render
vaccin
easier
make
safer
patient
regard
obstacl
mucos
immun
first
line
opposit
vaccin
encount
longlin
mucos
epithelium
report
measl
junin
virus
infect
polar
epithelium
releas
polar
way
perform
studi
evalu
interact
recombin
vaccinia
virus
epitheli
cell
determin
whether
epitheli
cell
releas
hiv
antigen
polar
way
upon
find
perform
test
see
influenc
polar
releas
antigen
deliveri
specif
immun
respons
report
recombin
hiv
vaccinia
viru
infect
mucos
epithelium
vitro
balbc
mice
progeni
vaccinia
viru
hiv
antigen
preferenti
releas
apic
surfac
colchicin
treatment
caus
unpolar
antigen
express
deliveri
enhanc
specif
immun
respons
result
provid
guidanc
immun
enhanc
dose
reduct
hiv
vaccin
human
colon
carcinoma
cell
line
vero
cell
line
obtain
american
type
cultur
collect
rockvil
md
us
cell
maintain
dmem
gibco
supplement
vv
fetal
bovin
serum
fb
gibco
mm
hepe
uml
penicillin
streptomycin
gibco
ps
amino
acid
memneaa
mm
gibco
vero
cell
maintain
otherwis
ident
dmem
medium
contain
neaa
incub
humidifi
atmospher
femal
balbc
mice
week
old
purchas
hunan
sja
laboratori
anim
co
ltd
maintain
anim
center
wuhan
institut
virolog
chines
academi
scienc
specif
pathogenfre
spf
condit
femal
mice
chosen
previou
studi
suggest
nasal
prime
work
well
male
mice
experi
approv
wuhan
institut
virolog
experiment
anim
ethic
welfar
committe
permit
number
rvttgagpol
vaccinia
viru
provid
dr
zhiwei
chen
director
hkuaid
institut
construct
dr
ke
zhuang
colleg
life
scienc
wuhan
univers
viru
homolog
recombin
gagpol
gene
gfp
gene
replac
vaccinia
viru
ha
gene
propag
vero
cell
cell
frozen
thaw
three
time
centrifug
rpm
minut
supernat
aspir
aliquot
store
virus
purifi
enrich
immun
largescal
propag
virus
vero
cell
supernat
frozen
thaw
cell
ad
mv
sucros
solut
centrifug
g
minut
deposit
suspend
aliquot
pfuml
pb
store
viral
titer
determin
plaqu
assay
vero
cell
mice
prime
boost
pfumous
rvttgagpol
week
euthan
week
fig
test
viral
antigen
distribut
mice
colchicin
group
inocul
colchicin
duchefa
hour
rvttgagpol
pfumous
immun
control
group
pb
replac
colchicin
fig
regard
specif
antibodi
respons
test
mice
colchicin
group
prime
rvttgagpol
pfumous
colchicin
boost
colchicin
hour
immun
rvttgagpol
pfumous
week
euthan
week
fig
immun
perform
anesthesia
mgg
pentobarbit
mice
group
euthanasia
vagin
wash
collect
forti
microlit
pb
aspir
vagin
tract
use
tip
fluid
blown
aspir
time
wash
twice
serum
obtain
collect
lung
bronchial
wash
bw
trachea
expos
surgic
breast
diaphragm
open
subsequ
lung
expans
small
cut
made
trachea
small
surgic
scissor
tip
cover
tip
pipett
use
aspir
pb
bsa
apparatu
care
insert
trachea
tip
toward
lung
blown
aspir
three
time
slowli
complet
wash
whole
lung
bronchia
vagin
wash
bw
centrifug
rpm
minut
store
mice
immun
euthan
hour
later
collect
method
similar
use
previous
heparin
uml
blood
collect
centrifug
rpm
nasal
wash
lung
bronchial
wash
collect
ml
dmem
ps
fb
method
collect
bronchial
wash
describ
nasal
wash
initi
step
use
bronchial
wash
small
cut
made
trachea
tip
cover
tip
pipett
care
insert
trachea
tip
toward
nostril
solut
made
flow
nostril
wash
twice
nasal
turbin
lung
separ
homogen
ml
dmem
ps
fb
wash
homogen
sampl
centrifug
rpm
minut
vaccinia
viral
titer
concentr
determin
plaqu
assay
elisa
respect
immun
mice
bled
euthan
nasal
turbin
lung
collect
fix
vv
formaldehyd
hour
decalcif
nasal
turbin
perform
cool
vv
nitric
acid
microwav
oven
decalcif
solut
maintain
immers
beaker
ice
refresh
everi
minut
hour
lung
decalcifi
nasal
turbin
sampl
underw
serial
dehydr
imbed
paraffin
cut
slice
thick
tissu
section
heat
rehydr
subject
antigen
retriev
procedur
includ
microwav
citrat
buffer
ph
incub
hydrogen
peroxid
deioniz
water
follow
experi
perform
use
zsgbbio
kit
tissu
section
block
minut
room
temperatur
incub
rabbit
gift
dr
bing
yan
wuhan
institut
virolog
chines
academi
scienc
hour
tissu
section
incub
biotinlabel
goat
antirabbit
antibodi
strephrp
separ
minut
room
temperatur
visual
use
diaminobenzidin
dab
kit
maixinbio
primari
antibodi
incub
sampl
wash
three
time
pb
primari
antibodi
incub
wash
three
time
pb
vv
tween
twice
pb
alon
slide
counterstain
hematoxylin
solut
slide
photograph
olympu
microscop
equip
qimag
ccd
camera
miropublish
rtv
qcaptur
vision
softwar
experi
perform
biosafeti
hood
use
asept
techniqu
vero
cell
seed
plate
incub
hour
serial
dilut
inocul
hour
inocula
remov
wash
ml
pb
freshli
prepar
mv
agaros
gibco
ps
ad
plate
incub
hour
ml
mgml
crystal
violet
formaldehyd
ad
fix
stain
cell
layer
hour
room
temperatur
agaros
care
flush
tap
water
plate
airdri
plaqu
count
pfu
plaqu
format
unit
p
plaqu
count
v
volum
inocula
antibodi
detect
e
coli
recombin
protein
coat
carbon
bicarbon
buffer
ph
hour
plate
block
bsa
pb
overnight
serial
dilut
sampl
pb
bsa
ad
plate
incub
hour
goat
antimous
iggap
southern
biotech
goat
antimous
igaap
southern
biotech
pb
bsa
ad
incub
hour
colorimetr
convers
perform
use
sigma
pnitrophenylphosph
pnpp
tablet
set
sigma
hour
incub
block
plate
wash
tween
pb
plate
evalu
micropl
spectrophotomet
multiskan
thermo
labsystem
nm
readout
calibr
blank
titer
sampl
calcul
endpoint
dilut
twice
neg
valu
protein
detect
doubl
antibodi
sandwich
method
use
dilut
rabbit
polyantibodi
coat
carbon
bicarbon
buffer
ph
hour
plate
block
use
fb
pb
overnight
plate
contain
treat
sampl
serial
dilut
pb
contain
fb
vv
treat
hour
releas
hivviruslik
particl
e
coli
recombin
dilut
manner
use
creat
standard
curv
determin
concentr
sampl
treat
untreat
sampl
dilut
place
well
hour
mous
antibodi
ad
incub
hour
colorimetr
convers
tmb
substrat
reagent
use
minut
room
temperatur
work
solut
follow
solut
b
ml
buffer
buffer
mm
potassium
citrat
ph
solut
b
mm
tmb
dmso
incub
block
plate
wash
tween
pb
colorimetr
convers
substrat
read
nm
nm
od
valu
od
valu
nm
od
valu
nm
standard
curv
drawn
linear
regress
equat
made
linear
rang
ngml
ngml
concentr
sampl
comput
use
equat
monolay
grown
corn
costar
transwel
plate
corn
inc
us
pore
filter
insert
cell
cultur
day
becom
confluent
took
day
medium
chang
everi
day
would
well
polar
ter
read
measur
millicel
voltmet
millipor
corp
us
polar
monolay
cell
infect
rvttgagpol
apic
moi
multipl
infect
viru
ad
directli
onto
apic
surfac
incub
fbscontain
dmem
medium
medium
ad
basolater
compart
viru
aspir
hour
apic
surfac
wash
three
time
pb
cultur
fed
fresh
medium
return
incub
infect
polar
monolay
cell
sampl
hour
postinfect
apic
basolater
media
collect
cell
frozen
thaw
three
time
final
three
type
sampl
apic
media
basolater
media
cell
aliquot
store
unpolar
group
starter
cell
seed
transwel
day
infect
rvttgagpol
colchicinetr
group
colchicin
mgml
ad
polar
cell
layer
hour
infect
fortyeight
hour
infect
apic
basolater
media
collect
fresh
medium
ad
sampl
collect
hour
viral
titer
determin
elisa
plaqu
assay
respect
viru
titer
time
calcul
sum
collect
hour
hour
experi
perform
doubl
triplic
monolay
rins
pb
fix
formaldehyd
glutaraldehyd
sodium
phosphat
buffer
ph
hour
follow
fixat
cell
filter
cut
free
plastic
insert
postfix
contrast
en
bloc
uranyl
acet
dehydr
grade
seri
ethanol
solut
embed
epon
section
cut
perpendicularli
filter
collect
formvarco
mesh
grid
examin
electron
microscop
statist
analys
conduct
use
graphpad
prism
version
statist
comparison
conduct
use
unpair
test
p
valu
consid
signific
evalu
mucos
immun
respons
associ
rvttgagpol
balbc
mice
intranas
administ
pfu
rvttgagpol
fig
week
two
immun
four
week
apart
mice
euthan
antibodi
level
determin
detail
serum
igg
titer
serum
iga
titer
lung
wash
iga
titer
vagin
wash
iga
titer
signific
differ
pb
group
found
fig
igg
titer
lung
wash
found
higher
iga
data
shown
howev
igg
level
stabl
mucos
surfac
vagin
wash
evalu
igg
show
highdos
rvttgagpol
immun
could
induc
high
level
igg
serum
low
iga
titer
suggest
weak
mucos
immun
respons
result
similar
report
group
one
studi
pfumous
recombin
vaccinia
viru
given
mice
week
mice
euthan
sampl
week
specif
iga
lung
wash
shown
via
od
valu
could
convert
titer
anoth
group
gave
mice
pfu
euthan
week
later
specif
antibodi
result
follow
serum
igg
serum
iga
bronchial
wash
iga
although
rvttgagpol
replic
viru
vaccin
still
need
high
dose
induc
even
small
mucos
immun
respons
mucos
immun
order
find
reason
behind
way
enhanc
immun
respons
reduc
dose
studi
interact
rvttgagpol
polar
epithelia
known
epitheli
cell
layer
polar
vivo
vitro
mucos
epitheli
cell
line
cultur
permeabl
membran
call
transwel
becom
polar
monolay
studi
human
colon
carcinoma
cell
line
cultur
develop
polar
cell
layer
rvttgagpol
inocul
apic
side
small
local
cytopath
effect
cpe
appear
cell
layer
loos
connect
form
neighbor
cell
great
effect
integr
monolay
infect
cell
monolay
fix
process
electron
microscopi
concentr
rvtt
viral
titer
apic
basolater
cell
sampl
determin
variou
time
point
polar
cell
monolay
observ
electron
microscopi
fig
viral
factori
present
cell
plasma
mani
round
immatur
vaccinia
virus
nm
diamet
fig
gagpol
assembl
hivviruslik
particl
vlp
nm
diamet
process
transport
fig
outsid
cell
apic
surfac
fig
matur
vaccinia
virus
nm
short
diamet
nm
long
diamet
observ
insid
cell
shown
outsid
apic
surfac
fig
vaccinia
virus
seen
outsid
basolater
surfac
kinet
viru
distribut
postinfect
shown
figur
f
concentr
dissoci
vlp
determin
use
doubl
antibodi
sandwich
elisa
disassoci
found
express
cell
releas
apic
basolater
surfac
vlp
evalu
use
result
suggest
increas
level
cellular
apic
releas
apic
surfac
well
basolater
vlp
still
could
detect
total
ngwell
found
present
cell
ngwell
present
apic
medium
none
detect
basolater
medium
viral
titer
determin
plaqu
assay
viru
found
replic
pfuwel
cell
releas
apic
surfac
time
level
basolater
medium
even
medium
chang
everi
hour
kinet
show
similar
trend
data
shown
rvttgagpol
infect
polar
cell
layer
assembl
progeni
vaccinia
virus
express
hiv
gene
releas
viral
product
apic
surfac
whether
situat
would
vivo
impact
preferenti
releas
might
specif
immun
respons
remain
determin
end
studi
interact
rvttgagpol
epithelium
balbc
mice
identifi
amount
locat
hiv
antigen
mice
immun
rvttgagpol
euthan
hour
later
plasma
nasal
wash
lung
bronchial
wash
homogen
nose
lung
tissu
sampl
collect
level
viru
sampl
detect
plaqu
assay
elisa
respect
result
show
mice
inocul
viru
replic
express
respiratori
system
blood
fig
b
c
e
f
virus
enter
nose
tissu
viral
level
decreas
lowest
point
pfu
hour
increas
first
second
day
reach
peak
hour
pfu
time
virus
releas
lumen
nose
viral
level
reach
lowest
point
pfu
hour
highest
point
pfu
hour
fig
express
distribut
took
similar
trend
largest
amount
express
achiev
ng
per
mous
hour
fig
virus
abl
reach
lung
volum
administr
exceed
ul
virus
replic
express
lung
fig
c
lowest
viru
level
detect
hour
highest
hour
viral
titer
found
reach
pfu
lower
nose
tissu
amount
reach
ng
volum
administr
ul
fewer
virus
reach
lung
peak
viral
titer
reach
pfu
per
mous
data
shown
howev
neither
viru
detect
blood
fig
f
show
infect
express
restrict
respiratori
system
order
determin
exact
locat
antigen
nose
lung
perform
immunoperoxidas
stain
antigen
mice
inocul
rvttgagpol
fig
h
j
hour
littl
epithelium
nose
fig
hour
larg
amount
remain
epithelium
small
amount
found
lamina
propria
fig
lung
littl
observ
hour
imag
shown
certain
amount
observ
epithelia
lung
hour
deliv
alveolar
cell
fig
immunohistochemistri
result
consid
repres
viral
distribut
rvttgagpol
found
capabl
infect
epitheli
cell
nose
lung
progeni
viru
constantli
releas
lumen
though
littl
reach
lamina
propria
result
correspond
vitro
experi
viral
infect
express
detect
respiratori
system
blood
far
vaccin
develop
concern
expect
antigen
would
deliv
primarili
whole
bodi
outsid
limit
effici
antigen
deliveri
found
due
polar
distribut
epithelium
also
suggest
polar
releas
barrier
induct
effici
immun
respons
one
approach
improv
situat
would
find
way
induc
unpolar
releas
viru
hiv
antigen
polar
bud
reli
upon
cytoskeleton
microtubul
depolymer
protein
ordinarili
target
apic
surfac
end
elsewher
colchicin
drug
inhibit
microtubul
polymer
caus
unpolar
releas
junin
viru
polar
vero
cell
use
colchicin
inhibit
polar
releas
follow
cell
allow
polar
day
colchicin
ad
apic
hour
rvttgagpol
infect
group
call
polar
colchicin
group
anoth
polar
group
infect
rvttgagpol
unpolar
group
consist
infect
unpolar
cell
cell
cultur
transwel
day
rvttgagpol
inocul
data
present
figur
calcul
sum
detect
hour
hour
compar
polarizedonli
group
unpolar
polar
colchicin
group
show
rel
unpolar
distribut
viru
fig
unpolar
group
total
amount
viru
significantli
higher
polar
group
progeni
virus
releas
apic
basolater
surfac
fig
colchicinetr
group
polar
bud
disturb
trend
distribut
similar
unpolar
group
compar
polar
group
amount
viru
cell
higher
amount
basolater
medium
time
higher
amount
apic
medium
lower
fig
distribut
show
similar
trend
colchicinetr
group
ter
decreas
transwel
fig
increas
transwel
low
concentr
mgml
decreas
high
concentr
mgml
data
shown
fig
b
transwel
data
shown
colchicin
treatment
induc
basolater
viral
releas
conclus
colchicin
treatment
hour
rvttgagpol
infect
found
caus
unpolar
releas
viru
vitro
next
impact
colchicin
antigen
distribut
explor
mice
epithelia
colchicin
inocul
hour
administr
rvttgagpol
pb
use
substitut
colchicin
control
group
mice
euthan
hour
plasma
nasal
wash
lung
bronchial
wash
homogen
nose
lung
tissu
collect
level
viru
sampl
measur
plaqu
assay
elisa
respect
result
demonstr
rel
rvttgagpol
group
colchicinetr
group
show
consist
higher
express
infect
rate
nose
nasal
wash
fig
b
time
higher
hour
time
higher
hour
lung
lung
bronchial
wash
viru
level
much
higher
hour
hour
began
decreas
reach
lowest
point
hour
fig
viru
detect
blood
colchicinetr
control
mice
data
shown
regard
distribut
nose
immunoperoxidas
stain
antigen
show
hour
colchicinetr
group
express
epithelium
much
higher
rate
group
immun
rvttgagpol
alon
level
lamina
propria
group
low
fig
f
hour
colchicinetr
group
express
much
higher
level
rvttgagpol
immun
group
epithelia
lamina
propria
fig
h
ascertain
toxic
revers
effect
colchicin
measur
bodi
weight
observ
condit
mice
everi
day
immun
bodi
weight
decreas
immun
restor
day
later
data
shown
gener
condit
mice
evalu
coat
smooth
activ
level
correspond
chang
bodi
weight
conclus
colchicin
treatment
found
depolar
releas
vaccinia
viru
vitro
immun
mice
mice
also
increas
level
next
task
examin
specif
immun
respons
establish
colchicin
treatment
group
determin
influenc
colchicin
treatment
specif
immun
respons
mice
administ
rvttgagpol
pfu
colchicin
time
week
mice
inocul
colchicin
hour
rvttgagpol
inocul
pb
use
substitut
colchicin
control
group
week
mice
euthan
blood
mucos
sampl
collect
colchicin
group
immun
respons
significantli
stronger
control
group
fig
serum
igg
titer
time
control
serum
iga
time
higher
lung
bronchial
wash
iga
titer
time
higher
vagin
wash
iga
titer
time
higher
gener
antibodi
titer
increas
depend
locat
induct
mucos
level
iga
increas
systemat
effect
iga
igg
level
observ
colchicin
given
mice
determin
effect
immun
respons
found
influenc
antibodi
respons
similar
dose
signific
effect
anyth
serum
iga
titer
show
lower
level
increas
seen
higher
dose
data
shown
condit
colchicin
treatment
detect
antigen
distribut
differ
slightli
use
evalu
immun
respons
although
use
treatment
procedur
note
enlarg
correspond
immun
respons
result
stabli
reproduc
result
shown
figur
howev
reproduc
consist
idea
colchicin
enhanc
immun
respons
mani
factor
might
influenc
immun
respons
point
antigen
distribut
immun
respons
data
suggest
unpolar
releas
vaccinia
viru
antigen
render
antibodi
respons
intens
purpos
present
studi
evalu
interact
hiv
recombin
vaccinia
viru
rvttgagpol
mucos
epithelium
relationship
antigen
distribut
specif
immun
respons
even
high
dose
vaccinia
viru
vaccin
candid
induc
strong
mucos
iga
respons
relat
protect
viral
challeng
studi
perform
dose
rvtt
rang
pfumous
low
specif
antibodi
titer
produc
larg
dose
harder
prepar
caus
side
effect
howev
administr
recombin
vaccinia
viru
alongsid
hn
f
found
protect
mice
challeng
sendai
viru
via
respiratori
duct
inocul
via
either
intranas
intraor
rout
recombin
vaccinia
viru
protein
sarscov
induc
time
level
nab
serum
induc
rmva
mean
increas
effici
reduc
dose
size
would
use
research
doctor
patient
interest
vaccin
vitro
experi
rvtt
immun
perform
via
mucosa
demonstr
rvttgagpol
could
infect
polar
epitheli
layer
progeni
viru
express
releas
mainli
apic
surfac
fig
vermeer
et
al
also
report
vaccinia
viru
infect
differenti
human
airway
epithelia
releas
mainli
apic
surfac
vitro
huang
et
al
report
siv
bud
basolater
polar
vero
cell
randal
et
al
report
polar
veropfn
cell
infect
vvgag
similar
amount
capsid
protein
releas
viru
particl
apic
basolater
surfac
contrast
cell
infect
vvgag
vvenv
associ
particl
releas
basolater
medium
result
indic
envelop
glycoprotein
render
viru
particl
contain
gag
protein
releas
basolater
surfac
howev
coinfect
polar
cell
rvttgagpol
rvttenv
via
apic
surfac
increas
associ
vlp
detect
basolater
medium
also
infect
polar
vero
cell
rvttgagpol
via
apic
surfac
integr
cell
layer
deterior
hour
infect
depend
moi
data
shown
cell
layer
broke
vaccinia
viru
mainli
releas
apic
surfac
viru
present
basolater
medium
apic
contrast
cell
layer
maintain
integr
infect
viru
still
releas
mainli
apic
surfac
reason
might
cell
epitheli
cell
colon
mucos
tissu
vero
cell
deriv
epitheli
cell
kidney
make
cell
repres
mucos
epithelia
vivo
vero
cell
verifi
interact
immun
mice
rvttgagpol
abl
infect
respiratori
system
though
virus
could
detect
blood
fig
mice
immun
rvttgagpol
via
vagina
viru
restrict
vagin
system
could
detect
blood
unpublish
data
group
found
similar
result
recombin
vaccinia
viru
shown
replic
nose
lung
inocul
without
viru
detect
blood
howev
ip
inocul
viru
detect
blood
day
anoth
studi
focus
activ
luciferas
variou
mous
tissu
immun
recombin
mva
intranas
intravagin
iv
intrarect
ir
rout
immun
luciferas
activ
detect
lung
nalt
lungdrain
lymph
node
tissu
ir
immun
model
activ
detect
rectum
rectal
lymph
node
tissu
similarli
iv
immun
activ
detect
ovari
vagin
lymph
node
activ
vagina
lumen
test
contrast
vaccinia
viru
vesicular
stomat
viru
vsv
found
releas
basolater
surfac
mdck
infect
vitro
vsv
type
new
jersey
vsvnj
inocul
deer
mice
infect
olfactori
epithelium
took
place
day
great
deal
viru
observ
lamina
propria
day
juvenil
adult
deer
mice
studi
develop
virusemia
day
result
impli
vsv
infect
epithelium
first
spread
lamina
propria
blood
unlik
vsv
vaccinia
virus
mainli
releas
lumen
difficult
enter
blood
lamina
propria
polar
releas
rvttgagpol
antigen
limit
antigen
deliveri
specif
immun
respons
use
colchicin
increas
effect
show
colchicin
act
disrupt
polar
releas
vitro
cell
layer
immun
mice
fig
vitro
pore
transwel
membran
use
make
sure
rvtt
releas
basolater
surfac
transwel
pore
abl
block
basolater
releas
show
mani
basolater
releas
virus
sampl
equip
pore
releas
antigen
significantli
differ
data
shown
impli
due
larg
size
vaccinia
viru
pass
transwel
pore
easili
pore
mice
colchicin
treatment
increas
viral
infect
express
nose
nasal
wash
lamina
propria
fig
damag
epithelium
consist
situat
vitro
cell
layer
turn
plaqu
maintain
integr
epitheli
layer
rel
well
one
explan
colchicin
treatment
abl
increas
rate
infect
express
may
colchicin
influenc
dissemin
cell
second
period
infect
rvttgagpol
infect
epitheli
cell
progeni
virus
releas
apic
surfac
infect
neighbor
cell
via
apic
surfac
fig
transport
reli
microtubul
depolymer
microtubul
colchicini
caus
vesicl
target
basolater
surfac
fig
basolater
target
vesicl
fuse
upper
two
third
later
surfac
region
immedi
beneath
tight
junction
addit
vaccinia
viru
readili
infect
differenti
human
airway
epithelia
basolater
surfac
apic
surfac
way
colchicin
treatment
render
infect
cell
much
like
infect
cell
result
demonstr
unpolar
releas
viru
antigen
increas
specif
antibodi
respons
studi
describ
impact
colchicin
immun
respons
colchicin
act
immun
suppressor
high
dose
immun
enhanc
low
dose
increas
immun
respons
coadminist
antigen
enhanc
immun
respons
factor
two
studi
dose
vitro
previou
report
indic
would
result
immun
suppress
found
colchicin
act
immun
enhanc
condit
addit
immun
enhanc
easili
enhanc
specif
immun
respons
protein
antigen
live
viral
vector
live
viral
vector
activ
natur
immun
respons
research
unpolar
releas
antigen
clear
fig
immun
effect
intens
widespread
fig
increas
specif
antibodi
respons
mainli
due
unpolar
releas
slightli
nonspecif
enhanc
immun
respons
studi
gag
antibodi
serv
repres
mucos
humor
respons
although
display
tradit
neutral
import
hiv
vaccin
first
iga
neutral
hiv
cell
intracellularli
proven
measl
one
member
team
unpublish
data
found
viral
replic
could
inhibit
bind
intern
protein
measl
specif
iga
epitheli
cell
phenomenon
name
intracellular
neutral
second
gag
gene
rel
conserv
specif
iga
abl
target
one
subtyp
hiv
env
gene
mutat
readili
studi
explor
interact
rvttgagpol
mucos
epitheli
cell
layer
impact
antigen
deliveri
specif
immun
respons
result
demonstr
rvttgagpol
infect
epitheli
cell
express
progeni
viru
mainli
releas
apic
surfac
vitro
mice
characterist
polar
distribut
restrict
deliveri
antigen
thu
specif
immun
respons
improv
upon
colchicin
use
depolar
distribut
facilit
antigen
express
deliveri
specif
immun
respons
report
polar
releas
viru
restrict
infect
research
yet
perform
relationship
polar
releas
antigen
deliveri
specif
immun
respons
result
provid
explan
low
effici
rvttgagpolinduc
mucos
immun
suppli
guidanc
vaccin
design
eye
toward
increas
immun
respons
decreas
dose
first
research
may
make
use
colchicin
lowtox
drug
increas
viral
antigen
distribut
epithelium
lamina
propria
second
may
develop
recombin
vaccinia
virus
use
gene
target
antigen
bud
basolater
surfac
protein
gene
vsv
third
may
select
virus
preferenti
releas
basolater
surfac
vsv
use
vaccin
vector
